Part of the upgrade Riverside Health System recently made to its Leksell Gamma Knife, a noninvasive radiosurgery machine that attacks brain tumors, had to be done in the dead of night. “They have to ...
Stereotactic radiosurgery appears to be feasible, safe, and effective for patients with 15 or more brain metastases and may be a viable alternative to whole brain radiation therapy (WBRT) alone in ...
Randomized comparisons of stereotactic radiation and whole-brain radiation for patients with more than four brain metastases have been lacking. A randomized trial showed that stereotactic radiation ...
Previous studies have shown that, for patients with four or fewer brain tumors, stereotactic radiation—which uses focused beams of high-dose radiation to target individual tumors—improves cognitive ...
Studies show that cardiologists who specialize in a surgical technique that involves radiation have higher rates of brain ...
Researchers are testing a radiation technique that compresses an entire cancer treatment dose into a fraction of a second, ...
About 40% of patients with brain metastases who experienced cognitive decline after brain radiation therapy regained full cognitive function within 6 months following treatment, a new analysis found.
In a Phase 3 randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors led to lower symptom burden, better cognitive outcomes, and better day to ...
Preoperative stereotactic radiotherapy (SRT) was just as safe as postoperative SRT for patients with resectable brain metastases. More patients treated with preoperative SRT completed both radiation ...
Brain tumors are abnormal growths of cells in or around the brain. They can be primary (originating in the brain) or secondary (metastatic, spreading to the brain from cancer elsewhere). They can also ...
Stereotactic radiation improved key quality-of-life outcomes among patients with multiple brain metastases compared with hippocampal-avoidance whole-brain radiation (HA-WBRT), a phase III randomized ...